Microsoft

IP Roundup

Premium

Northwestern University, Sierra Molecular, Rosetta Inpharmatics, OnChip Cellomics Consortium, Vanderbilt University, Enzo Life Sciences

IP Roundup

Premium

University of Missouri, the United States of America, the State of Oregon, GE Healthcare, Combimatrix, CalTech, Amic, Rosetta Inpharmatics

Shire Owings Mills (Md.) Plant, Alexandria Real Estate Equities, Takeda Pharmaceutical, Wareham Development, PATH, Fall River (Mass.) Executive Park, University of Massachusetts/Dartmouth Bioprocessing Facility, Silicon Border, Sapphire Engineering, Campanelli Business Park, University of California-Davis M.I.N.D., Institute, Doe & Ingalls of North Carolina, Covaris, Life Technologies, BioMed Realty Trust, Shasun Pharma Solutions

The school will use the Syllego system for diabetes-related genome-wide association studies.

Navigenics decided to acquire Affy’s 10,000-square-foot Clinical Services Lab in Sacramento, Calif., after seeing an increase in the volume of orders for its genetic screening service. In addition to the advantages of having an internal CLIA lab, however, the consumer genomics firm will now have to navigate a complex regulatory environment.

New Product Watch

Premium

Affymetrix, Genisphere, Febit, Rosetta Biosoftware, NuGen Technologies

New Products

Premium

Thermo Fisher Scientific, Stratatech, Beckman Coulter

Downloads and Upgrades

Premium

ArrayStar v3.0, QSeq, Protein Center, Labworks LIMS 6.1, Ontology Add-in for Microsoft Office Word 2007, IQ 5400S, IQ 36000X

Migrations

Premium

Dan Shoemaker

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.